Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings

Shares (Q2 2026)
30,883
Value
$8.24M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ASND by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202630,883$8.24M<0.1%+29,821+2,808.0%AddedHolders
Q1 20261,062$242.9K<0.1%−124,706−99.2%ReducedHolders
Q4 2025125,768$26.8M<0.1%+122,182+3,407.2%AddedHolders
Q3 20253,586$712.9K<0.1%−3,600−50.1%ReducedHolders
Q2 20257,186$1.24M<0.1%−13,340−65.0%ReducedHolders
Q1 202520,526$3.20M<0.1%−17,454−46.0%ReducedHolders
Q4 202437,980$5.23M<0.1%−52,400−58.0%ReducedHolders
Q3 202490,380$13.5M<0.1%−191,157−67.9%ReducedHolders
Q2 2024281,537$38.4M0.1%−58,581−17.2%ReducedHolders
Q1 2024340,118$51.4M0.1%+74,961+28.3%AddedHolders
Q4 2023265,157$33.4M<0.1%+44,604+20.2%AddedHolders
Q3 2023220,553$20.7M<0.1%+88,470+67.0%AddedHolders
Q2 2023132,083$11.8M<0.1%−7,133−5.1%ReducedHolders
Q1 2023139,216$14.9M<0.1%+22,512+19.3%AddedHolders
Q4 2022116,704$14.3M<0.1%+24,894+27.1%AddedHolders
Q3 202291,810$9.48M<0.1%−7,972−8.0%ReducedHolders
Q2 202299,782$9.28M<0.1%−52,177−34.3%ReducedHolders
Q1 2022151,959$17.8M<0.1%−2,661−1.7%ReducedHolders
Q4 2021154,620$20.8M<0.1%+129,793+522.8%AddedHolders
Q3 202124,827$3.96M<0.1%+18,710+305.9%AddedHolders
Q2 20216,117$805.0K<0.1%−2,250−26.9%ReducedHolders
Q1 20218,367$1.08M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.